As the expression levels of OCTN2 and ATB0,+ are higher in colon cancer cells than in normal colon cells, LC-PLGA NPs can be used to deliver chemotherapeutic drugs selectively to cancer cells for colon cancer therapy. Here, SLC22A5 is linked to cancer.